Diego Garzon
Company: Apertura Gene Therapy
Job title: Vice President
Seminars:
8:45AM Chair’s Opening Remarks 8:45 am
day: Conference Day 2
9:00AM Case Study: Effective Strategies to Identify, Reduce, & Manage Pre- Existing Antibodies to Expand Patient Eligibility in Gene Therapy 9:00 am
• How prevalent is pre-existing AAV immunity in different patient populations? • Discuss screening and stratification techniques to identify AAV-positive patients • Explore approaches like plasmapheresis, vector engineering, and alternative serotypes to bypass antibody responseRead more
day: Conference Day 2